Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-013053
Filing Date
2016-02-10
Accepted
2016-02-10 19:56:31
Documents
1
Period of Report
2016-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4077
  Complete submission text file 0000899243-16-013053.txt   5427
Mailing Address 65 HAYDEN AVE LEXINGTON MA 02421
Business Address
BONNEY MICHAEL W (Reporting) CIK: 0001219016 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 161407540

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations